These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

186 related articles for article (PubMed ID: 28114938)

  • 1. Closed-loop for type 1 diabetes - an introduction and appraisal for the generalist.
    Bally L; Thabit H; Hovorka R
    BMC Med; 2017 Jan; 15(1):14. PubMed ID: 28114938
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Is an artificial pancreas (closed-loop system) for Type 1 diabetes effective?
    Boughton CK; Hovorka R
    Diabet Med; 2019 Mar; 36(3):279-286. PubMed ID: 30183096
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Glucose-responsive insulin delivery for type 1 diabetes: The artificial pancreas story.
    Bally L; Thabit H; Hovorka R
    Int J Pharm; 2018 Jun; 544(2):309-318. PubMed ID: 29258910
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effect of 6 months of hybrid closed-loop insulin delivery in adults with type 1 diabetes: a randomised controlled trial protocol.
    McAuley SA; de Bock MI; Sundararajan V; Lee MH; Paldus B; Ambler GR; Bach LA; Burt MG; Cameron FJ; Clarke PM; Cohen ND; Colman PG; Davis EA; Fairchild JM; Hendrieckx C; Holmes-Walker DJ; Horsburgh JC; Jenkins AJ; Kaye J; Keech AC; King BR; Kumareswaran K; MacIsaac RJ; McCallum RW; Nicholas JA; Sims C; Speight J; Stranks SN; Trawley S; Ward GM; Vogrin S; Jones TW; O'Neal DN
    BMJ Open; 2018 Jun; 8(6):e020274. PubMed ID: 29886443
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Closed-loop insulin delivery in suboptimally controlled type 1 diabetes: a multicentre, 12-week randomised trial.
    Tauschmann M; Thabit H; Bally L; Allen JM; Hartnell S; Wilinska ME; Ruan Y; Sibayan J; Kollman C; Cheng P; Beck RW; Acerini CL; Evans ML; Dunger DB; Elleri D; Campbell F; Bergenstal RM; Criego A; Shah VN; Leelarathna L; Hovorka R;
    Lancet; 2018 Oct; 392(10155):1321-1329. PubMed ID: 30292578
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A fully artificial pancreas versus a hybrid artificial pancreas for type 1 diabetes: a single-centre, open-label, randomised controlled, crossover, non-inferiority trial.
    Tsoukas MA; Majdpour D; Yale JF; Fathi AE; Garfield N; Rutkowski J; Rene J; Legault L; Haidar A
    Lancet Digit Health; 2021 Nov; 3(11):e723-e732. PubMed ID: 34580055
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Do-it-yourself closed-loop systems for people living with type 1 diabetes.
    Dowling L; Wilmot EG; Choudhary P
    Diabet Med; 2020 Dec; 37(12):1977-1980. PubMed ID: 32420640
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The Artificial Pancreas and Type 1 Diabetes.
    Nwokolo M; Hovorka R
    J Clin Endocrinol Metab; 2023 Jun; 108(7):1614-1623. PubMed ID: 36734145
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Training and Support for Hybrid Closed-Loop Therapy.
    Boughton CK; Hartnell S; Allen JM; Fuchs J; Hovorka R
    J Diabetes Sci Technol; 2022 Jan; 16(1):218-223. PubMed ID: 32914648
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Glucose Control in Adults with Type 1 Diabetes Using a Medtronic Prototype Enhanced-Hybrid Closed-Loop System: A Feasibility Study.
    Lee MH; Vogrin S; Paldus B; Jones HM; Obeyesekere V; Sims C; Wyatt SA; Ward GM; McAuley SA; MacIsaac RJ; Krishnamurthy B; Sundararajan V; Jenkins AJ; O'Neal DN
    Diabetes Technol Ther; 2019 Sep; 21(9):499-506. PubMed ID: 31264889
    [No Abstract]   [Full Text] [Related]  

  • 11. Assessing the effectiveness of 3 months day and night home closed-loop insulin delivery in adults with suboptimally controlled type 1 diabetes: a randomised crossover study protocol.
    Leelarathna L; Dellweg S; Mader JK; Barnard K; Benesch C; Ellmerer M; Heinemann L; Kojzar H; Thabit H; Wilinska ME; Wysocki T; Pieber TR; Arnolds S; Evans ML; Hovorka R;
    BMJ Open; 2014 Sep; 4(9):e006075. PubMed ID: 25186158
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Bringing closed-loop home: recent advances in closed-loop insulin delivery.
    Thabit H; Hovorka R
    Curr Opin Endocrinol Diabetes Obes; 2014 Apr; 21(2):95-101. PubMed ID: 24569550
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Assessing the effectiveness of a 3-month day-and-night home closed-loop control combined with pump suspend feature compared with sensor-augmented pump therapy in youths and adults with suboptimally controlled type 1 diabetes: a randomised parallel study protocol.
    Bally L; Thabit H; Tauschmann M; Allen JM; Hartnell S; Wilinska ME; Exall J; Huegel V; Sibayan J; Borgman S; Cheng P; Blackburn M; Lawton J; Elleri D; Leelarathna L; Acerini CL; Campbell F; Shah VN; Criego A; Evans ML; Dunger DB; Kollman C; Bergenstal RM; Hovorka R
    BMJ Open; 2017 Jul; 7(7):e016738. PubMed ID: 28710224
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Closing the Loop in Adults, Children and Adolescents With Suboptimally Controlled Type 1 Diabetes Under Free Living Conditions: A Psychosocial Substudy.
    Barnard KD; Wysocki T; Ully V; Mader JK; Pieber TR; Thabit H; Tauschmann M; Leelarathna L; Hartnell S; Acerini CL; Wilinska ME; Dellweg S; Benesch C; Arnolds S; Holzer M; Kojzar H; Campbell F; Yong J; Pichierri J; Hindmarsh P; Heinemann L; Evans ML; Hovorka R
    J Diabetes Sci Technol; 2017 Nov; 11(6):1080-1088. PubMed ID: 28367636
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Insulin delivery and nocturnal glucose control in children and adolescents with type 1 diabetes.
    Tauschmann M; Hovorka R
    Expert Opin Drug Deliv; 2017 Dec; 14(12):1367-1377. PubMed ID: 28819992
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Diabetes technology and treatments in the paediatric age group.
    Shalitin S; Peter Chase H
    Int J Clin Pract Suppl; 2011 Feb; (170):76-82. PubMed ID: 21323816
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Feasibility study of automated overnight closed-loop glucose control under MD-logic artificial pancreas in patients with type 1 diabetes: the DREAM Project.
    Nimri R; Atlas E; Ajzensztejn M; Miller S; Oron T; Phillip M
    Diabetes Technol Ther; 2012 Aug; 14(8):728-35. PubMed ID: 22853723
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Closed-Loop Artificial Pancreas Therapy for Type 1 Diabetes.
    Zhou K; Isaacs D
    Curr Cardiol Rep; 2022 Sep; 24(9):1159-1167. PubMed ID: 35727409
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Towards the Integration of an Islet-Based Biosensor in Closed-Loop Therapies for Patients With Type 1 Diabetes.
    Olçomendy L; Cassany L; Pirog A; Franco R; Puginier E; Jaffredo M; Gucik-Derigny D; Ríos H; Ferreira de Loza A; Gaitan J; Raoux M; Bornat Y; Catargi B; Lang J; Henry D; Renaud S; Cieslak J
    Front Endocrinol (Lausanne); 2022; 13():795225. PubMed ID: 35528003
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Closing the Loop on Exercise in Type 1 Diabetes.
    Bally L; Thabit H
    Curr Diabetes Rev; 2018; 14(3):257-265. PubMed ID: 28245784
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.